BioSpace News Archive

Optim LLC, a premier manufacturer of proprietary flexible endoscopes for use in the visual diagnosis of Ear-Nose-and-Throat (“ENT”) disorders, announced today it has been chosen by 21st Century Oncology as the Preferred Vendor for new and replacement equipment used to diagnose and manage head and neck cancer disorders.

PTC Therapeutics, Inc., (NASDAQ: PTCT) is pleased to announce the recipients of the Company’s 2018 global STRIVE Awards (Strategies to Realize Innovation, Vision and Empowerment) program, designed to support nonprofit organizations serving the Duchenne muscular dystrophy community.

Infinitus (China), the sole sponsor of the event, brings new health solutions to Kazakhstan

Watercrest Senior Living Group proudly announces Robert Harwood as Community Relations Director of Watercrest Lake Nona Assisted Living and Memory Care Community.

Scilex Pharmaceuticals Inc. (Scilex), a subsidiary of Sorrento Therapeutics, Inc. (NASDAQ: SRNE) (Sorrento), today announced data showing ZTlido™ (lidocaine topical system) 1.8% (ZTlido) demonstrated a statistically significant improved adhesion profile compared to Lidoderm® (lidocaine patch 5%) (Lidoderm) and Versatis® (Medicated Plaster 5%) (Versatis)

Jake Williams, executive director of Healthier Colorado, issued the following statement today regarding Colorado’s lawsuit against Purdue Pharma, which alleges Purdue mislead providers and consumers about the addiction risks associated with prescription opioids.

CureDuchenne, a national venture philanthropy nonprofit focused on finding a cure for Duchenne muscular dystrophy (DMD), announced today a $500,000 investment into 4D Molecular Therapeutics (4DMT), a world-leader in Therapeutic Vector Evolution for adeno-associated virus (AAV) gene therapy vector discovery and product development, in an effort to advance gene therapy.

“Some people are more prone to urinary tract infections than others, so they need to take special precautions,” said an inventor from Scotch Plains, N.J. “In order to form a barrier so that bacteria and fungus cannot enter the urethra, I came up with this idea.”

The Hearing Loss Association of America (HLAA) invites you to join us on September 23 for the 2018 NYC Walk4Hearing.

Alexion Pharmaceuticals today announced that management will present at Morgan Stanley’s 16th Annual Global Healthcare Conference in New York, NY on Friday, September 14, 2018 at 11:05 a.m., EDT.